To test the clinical relevance of the loss of CBX6-mediated silencing in mesothelioma progression, we performed immunohistochemical staining of CBX6 in human normal mesothelium and mesothelioma tissues (Fig. 9, Fig. S7). Here, CBX6 is linked to mesothelioma.